Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 2
2008 3
2009 6
2010 1
2011 4
2012 3
2014 10
2015 11
2016 12
2017 3
2018 3
2019 10
2020 14
2021 20
2022 32
2023 24
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
The nano-revolution in the diagnosis and treatment of endometriosis.
Volpini C, Bloise N, Dominoni M, Barra F, Vellone VG, Minzioni P, Gardella B, Ferrero S, Visai L. Volpini C, et al. Among authors: gardella b. Nanoscale. 2023 Nov 9;15(43):17313-17325. doi: 10.1039/d3nr03527a. Nanoscale. 2023. PMID: 37874212 Review.
The role of fulvestrant in endometrial cancer.
Bogliolo S, Cassani C, Dominoni M, Orlandini A, Ferrero S, Iacobone AD, Viazzo F, Venturini PL, Spinillo A, Gardella B. Bogliolo S, et al. Among authors: gardella b. Expert Opin Drug Metab Toxicol. 2017 May;13(5):537-544. doi: 10.1080/17425255.2016.1244264. Epub 2016 Oct 19. Expert Opin Drug Metab Toxicol. 2017. PMID: 27696906 Review.
Aromatase inhibitors in the pharmacotherapy of endometriosis.
Gardella B, Rispoli E, Pasquali MF, Mauri M, Musacchi V, Dominoni M. Gardella B, et al. Expert Opin Pharmacother. 2023 Jun;24(9):1067-1073. doi: 10.1080/14656566.2023.2209315. Epub 2023 May 3. Expert Opin Pharmacother. 2023. PMID: 37128968 Review.
Advances in pharmacotherapy for treating endometriosis.
Tafi E, Leone Roberti Maggiore U, Alessandri F, Bogliolo S, Gardella B, Vellone VG, Grillo F, Mastracci L, Ferrero S. Tafi E, et al. Among authors: gardella b. Expert Opin Pharmacother. 2015;16(16):2465-83. doi: 10.1517/14656566.2015.1085510. Epub 2015 Sep 7. Expert Opin Pharmacother. 2015. PMID: 26569155 Review.
New Perspectives in Therapeutic Vaccines for HPV: A Critical Review.
Gardella B, Gritti A, Soleymaninejadian E, Pasquali MF, Riemma G, La Verde M, Schettino MT, Fortunato N, Torella M, Dominoni M. Gardella B, et al. Medicina (Kaunas). 2022 Jun 28;58(7):860. doi: 10.3390/medicina58070860. Medicina (Kaunas). 2022. PMID: 35888579 Free PMC article. Review.
Oxaliplatin for the treatment of ovarian cancer.
Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Bogliolo S, et al. Among authors: gardella b. Expert Opin Investig Drugs. 2015;24(9):1275-86. doi: 10.1517/13543784.2015.1062874. Epub 2015 Jun 30. Expert Opin Investig Drugs. 2015. PMID: 26125301 Review.
Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Zapardiel I, Gracia Segovia M, Macuks R, Mancari R, Achimas-Cadariu P, Corrado G, Bartusevicius A, Sukhin V, Muruzabal JC, Coronado Martín PJ, Gardella B, Piek JM, Concin N, Arab C, Papatheodorou D, Polterauer S, Iacoponi S, Nieto T, Lopez-Sanclemente MC, Trukhan H, Gil MM, Bakinovskaya I, Dalamanava A, Cucurull M, Rovski D, Baquedano L, Chiva L, Mardas M, Mavrichev SA, Klat J, Lopez de la Manzanara CA, Yildirim Y; SARCUT Study Group. Zapardiel I, et al. Among authors: gardella b. Int J Gynecol Cancer. 2023 Jun 5;33(6):897-904. doi: 10.1136/ijgc-2022-004204. Int J Gynecol Cancer. 2023. PMID: 37192761
147 results